LONGITUDINAL MICROVASCULAR AND NEURONAL RETINAL EVALUATION IN PATIENTS WITH DIABETES MELLITUS TYPES 1 AND 2 AND GOOD GLYCEMIC CONTROL

This study showed longitudinal changes in microvascular macular parameters of patients with Type 2 diabetes mellitus, no diabetic retinopathy, and good glycemic control, which could be interpreted as an attempt to preserve a balance between superficial and deeper layers to maintain retinal function in the earliest phases of diabetic retinal disease. Purpose: To evaluate microvascular and neuronal changes over 3 years in patients with Type 1/2 diabetes mellitus (DM1/DM2), good metabolic control, and no signs of diabetic retinopathy. Methods: In this prospective, longitudinal study, 20 DM1, 48 DM2, and 24 controls underwent macular optical coherence tomography and optical coherence tomography angiography at baseline and after 3 years. Following parameters were considered: thickness of the central macula, retinal nerve fiber layer, ganglion cell (GCL+/GCL++) complex; perfusion and vessel density and fractal dimension at the superficial and deep capillary plexuses; choriocapillaris flow deficits; and foveal avascular zone metrics. MATLAB and ImageJ were used for optical coherence tomography angiography scans analyses. Results: The mean HbA1c was 7.4 ± 0.8% in DM1 and 7.2 ± 0.8% in DM2 at baseline, with no change at 3 years. No eye developed diabetic retinopathy. In longitudinal analyses, perfusion density at superficial capillary plexuses (P = 0.03) and foveal avascular zone area and perimeter (P < 0.0001) significantly increased in DM2 compared with other groups. No longitudinal changes occurred in optical coherence tomography parameters. In comparisons within groups, DM2 had a significant thinning of GCL++ in the outer ring, decreased perfusion density at deep capillary plexuses and choriocapillaris flow deficits, and increase in foveal avascular zone perimeter and area in deep capillary plexuses; DM1 had an increase in foveal avascular zone perimeter in deep capillary plexuses (P < 0.001 for all comparisons). Conclusion: Longitudinal data showed significant microvascular retinal changes in DM2. No changes were detected in neuronal parameters and in DM1. Longer and larger studies are needed to confirm these preliminary data.

[1]  W. Chan,et al.  Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy , 2021, Journal of ophthalmology.

[2]  U. Schmidt-Erfurth,et al.  Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease , 2020, British Journal of Ophthalmology.

[3]  G. Schwartz,et al.  Reversed Neurovascular Coupling on Optical Coherence Tomography Angiography Is the Earliest Detectable Abnormality before Clinical Diabetic Retinopathy , 2020, Journal of clinical medicine.

[4]  G. Virgili,et al.  Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes , 2020, Scientific Reports.

[5]  Jennifer K. Sun,et al.  Vascular Density of Deep, Intermediate and Superficial Vascular Plexuses Are Differentially Affected by Diabetic Retinopathy Severity , 2020, Investigative ophthalmology & visual science.

[6]  Stephen J. Aldington,et al.  The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial , 2020, Journal of clinical medicine.

[7]  G. Coscas,et al.  Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy , 2020, Acta Diabetologica.

[8]  Copyright. , 2020, Physical medicine and rehabilitation clinics of North America.

[9]  J. Cunha-Vaz,et al.  Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study , 2020, Investigative ophthalmology & visual science.

[10]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[11]  P. Nucci,et al.  Early Detection of Microvascular Changes in Patients with Diabetes Mellitus without and with Diabetic Retinopathy: Comparison between Different Swept-Source OCT-A Instruments , 2019, Journal of diabetes research.

[12]  Rachel E Linderman,et al.  Earliest Evidence of Preclinical Diabetic Retinopathy Revealed Using Optical Coherence Tomography Angiography Perfused Capillary Density. , 2019, American journal of ophthalmology.

[13]  Luis de Sisternes,et al.  Accurate estimation of choriocapillaris flow deficits beyond normal intercapillary spacing with swept source OCT angiography. , 2018, Quantitative imaging in medicine and surgery.

[14]  Amani A. Fawzi,et al.  Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy , 2018, Investigative ophthalmology & visual science.

[15]  Stela Vujosevic,et al.  EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY , 2017, Retina.

[16]  Eric M. Moult,et al.  Quantifying Microvascular Changes Using OCT Angiography in Diabetic Eyes without Clinical Evidence of Retinopathy. , 2017, Ophthalmology. Retina.

[17]  M. Abràmoff,et al.  Diabetic retinopathy is a neurodegenerative disorder , 2017, Vision Research.

[18]  A. Papazafiropoulou,et al.  Type 2 diabetes and quality of life , 2017, World journal of diabetes.

[19]  Jennifer K. Sun,et al.  Diabetic Retinopathy: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.

[20]  Carmen A. Puliafito,et al.  Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography , 2016, Investigative ophthalmology & visual science.

[21]  Milan Sonka,et al.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus , 2016, Proceedings of the National Academy of Sciences.

[22]  Harsha L Rao,et al.  Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography. , 2015, Investigative ophthalmology & visual science.

[23]  A. Mori,et al.  Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats. , 2015, Experimental eye research.

[24]  L. Aiello Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.

[25]  Edoardo Midena,et al.  Retinal Layers Changes in Human Preclinical and Early Clinical Diabetic Retinopathy Support Early Retinal Neuronal and Müller Cells Alterations , 2013, Journal of diabetes research.

[26]  T. Gardner,et al.  Predicting Development of Proliferative Diabetic Retinopathy , 2013, Diabetes Care.

[27]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. , 2008, Ophthalmology.

[28]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[29]  Torsten B. Moeller,et al.  Books Received Pocket Atlas of Sectional Anatomy — Volume I : Head and Neck : 4th Edition Copyright © North American Neuro- O phthalmology Society . Unauthorized reproduction of this article is prohibited . , 2018 .